Anadis Opens New Approach to Respiratory Disease Control

kavin submitted, created time 2 months 3 weeks (www.medicalnewstoday.com)

Anadis Limited (ASX: ANX), a research-driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.

Working with an animal influenza challenge model in the laboratory of Professor Loreena Brown at the Department of Microbiology and Immunology, University of Melbourne, scientists successfully completed a series of proof-in-principal experiments

3 comments | Blog It | Email It | Keywords: antibodies drug discovery the flu influenza influenza A viruses influenza A virus influenza B virus avian influenza virus

Identification of H2N3 influenza A viruses from swine in the United States

davidd submitted, created time 10 months 2 weeks (www.pnas.org)

In this report, they isolate and characterize genetically similar avian/swine virus reassortant H2N3 influenza A viruses isolated from diseased swine from two farms in the United States. The H2N3 viruses were able to cause disease in experimentally infected swine and mice without prior adaptation. In addition, the swine H2N3 virus was infectious and highly transmissible in swine and ferrets. Taken together, these findings suggest that the H2N3 virus has undergone some adaptation to the mammalian host and that their spread should be very closely monitored.

1 comment | Blog It | Email It | Keywords: drug-resistant viruses drug resistance adaptive radiation viruses influenza pigs swine H2N3 influenza A viruses